Galectin Therapeutics GALT
NASDAQ GALT
$3.91 -0.02 (-0.51%)
At close: Sep 29, 2026 · 4:00 PM EDT

Galectin Therapeutics (GALT) Enterprise Value (2010 - 2026)

Updated

Galectin Therapeutics (GALT) recorded Enterprise Value of $294.39 million in Q2 2026, up 142.5% from $121.4 million a year earlier and up 73.5% from the prior quarter.

Analysis

Galectin Therapeutics (GALT) Enterprise Value (2010 - 2026) Analysis & Trends

On a TTM basis, Galectin Therapeutics' Enterprise Value came in at $251.03 million as of Jun 30, 2026, up 249.7% year-over-year; for FY2025, it was $253.52 million, up 282.1% from FY2024.

  • Annual Enterprise Value has a five-year compound annual growth rate of 20.3% (FY2020 to FY2025).
  • Across earlier years, Enterprise Value came in at $66.35 million in FY2024 (-13.8%), $77.02 million in FY2023 (+58.6%), $48.56 million in FY2022 (-41.6%) and $83.19 million in FY2021 (-17.4%).
  • The Q2 2026 figure is the highest quarterly Enterprise Value since Q1 2014.
  • On a year-over-year basis, Enterprise Value has increased for five consecutive quarters, with growth averaging 80.4% over the last eight quarters.
  • Peak year-over-year performance for Enterprise Value in the last five years was growth of 282.1% in Q4 2025, against a decline of 66.1% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $169.63 million (Q1 2026), $253.52 million (Q4 2025) and $261.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Galectin Therapeutics 260.61 Mn 260.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 294.39 Mn
Mar 31, 2026 169.63 Mn
Dec 31, 2025 253.52 Mn
Sep 30, 2025 261.84 Mn
Jun 30, 2025 121.40 Mn
Mar 31, 2025 69.78 Mn
Dec 31, 2024 66.35 Mn
Sep 30, 2024 144.29 Mn
Jun 30, 2024 115.15 Mn
Mar 31, 2024 124.98 Mn
Dec 31, 2023 77.02 Mn
Sep 30, 2023 98.39 Mn
Jun 30, 2023 67.83 Mn
Mar 31, 2023 107.32 Mn
Dec 31, 2022 48.56 Mn
Sep 30, 2022 81.03 Mn
Jun 30, 2022 53.63 Mn
Mar 31, 2022 64.01 Mn
Dec 31, 2021 83.19 Mn
Sep 30, 2021 193.64 Mn
API Access

Galectin Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=GALT&period=max&api_key=YOUR_API_KEY